No definition available.
Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue
CD2_PRIMARY_LYMPHOID_HEMATOPOIETIC_NAS_EXALLC
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- C81-C96
- Name in latin
- Neoplasmata maligna alia et non specificata textus lymphatici, haematopoetici et cognati
Similar endpoints
↥List of similar endpoints to
Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue
based on the number of shared cases.
Similar with more cases:
- Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue
- Primary_lymphoid and hematopoietic malignant neoplasms
- Primary_lymphoid and hematopoietic malignant neoplasms
- Malignant neoplasm
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 314 | 146 | 168 |
| Unadjusted period prevalence (%) | 0.06 | 0.05 | 0.07 |
| Median age at first event (years) | 55.73 | 53.03 | 58.08 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 289
- Matched controls
- 2888
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
209.5
161.7
156
16
C96.9
ICD-10 Finland
Malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified
+∞
155.7
135
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
718.4
61.1
58
*
L03AA02
ATC
filgrastim; parenteral
642.2
55.5
53
*
A03FA01
ATC
metoclopramide; systemic, rectal
9.6
49.6
115
186
XW000
NOMESCO Finland
Bone marrow biopsy
21.8
48.8
73
44
JN4BD
NOMESCO Finland
Extensive body CT
14.4
47.1
84
80
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
45.0
42
*
20298
ICD-8 Finland
Other neoplasms of lymphoid tissue, Lymphomata alia
+∞
43.9
41
*
H02AB02
ATC
dexamethasone; systemic
48.4
43.3
52
13
A04AA01
ATC
ondansetron; systemic, rectal
26.3
38.8
54
25
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
+∞
36.2
34
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
31.9
30
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
322.7
29.3
29
*
WW500
NOMESCO Finland
Blood transfusion
18.0
29.3
46
30
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
309.9
28.3
28
*
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
10.4
27.6
56
65
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
27.5
26
*
C96.2
ICD-10 Finland
Malignant mast cell tumour
+∞
25.4
24
*
20199
ICD-8 Finland
Hodgkin's disease
+∞
25.4
24
*
A04AA02
ATC
granisetron; systemic, transdermal
+∞
24.3
23
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
23.2
22
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
130.4
22.9
24
*
JN4AD
NOMESCO Finland
Body CT examination
14.4
22.4
38
30
L03AA13
ATC
pegfilgrastim; parenteral
+∞
22.2
21
*
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
18.2
22.0
34
21
WF002
NOMESCO Finland
Radical radiotherapy
+∞
21.1
20
*
130
Kela drug reimbursment
Malignant tumour
+∞
21.1
20
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
21.1
20
*
N02AA05
ATC
oxycodone; systemic
4.9
20.4
73
185
PJA10
NOMESCO Finland
Exploration of lymph nodes
62.2
20.2
23
*
ZX120
NOMESCO Finland
Intravenous
6.0
20.2
59
118
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
+∞
20.0
19
*
C96.7
ICD-10 Finland
Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue
+∞
20.0
19
*
C81.9
ICD-10 Finland
Hodgkin lymphoma, unspecified
+∞
20.0
19
*
Q82.2
ICD-10 Finland
Mastocytosis
214.1
19.8
20
*
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
49.8
19.5
23
5
R50.9
ICD-10 Finland
Fever, unspecified
4.5
19.2
75
207
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
75.1
19.0
21
*
C81.1
ICD-10 Finland
Nodular sclerosis classical Hodgkin lymphoma
+∞
19.0
18
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
17.9
17
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
101.4
17.8
19
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
191.2
17.7
18
*
XX3DW
NOMESCO Finland
Time consuming IT work
8.7
17.0
37
48
C82.1
ICD-10 Finland
Follicular lymphoma grade II
+∞
16.8
16
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.9
16.5
58
142
M04AA01
ATC
allopurinol; systemic
3.9
16.5
77
248
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
15.8
15
*
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
+∞
15.8
15
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
15.8
15
*
A02BC02
ATC
pantoprazole; systemic
2.9
15.4
212
1405
Z51.5
ICD-10 Finland
Palliative care
11.8
15.4
28
26
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
25.0
15.3
21
9
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
3.1
15.3
104
441
1XC02
NOMESCO Finland
NA
33.7
15.0
19
6
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
14.7
14
*
115
Kela drug reimbursment
Breast cancer
+∞
14.7
14
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
14.7
14
*
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
157.6
14.6
15
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
15.5
14.3
23
16
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
+∞
13.6
13
*
C82.9
ICD-10 Finland
Follicular lymphoma, unspecified
+∞
13.6
13
*
C90.0
ICD-10 Finland
Multiple myeloma
+∞
13.6
13
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.5
12.6
149
862
20293
ICD-8 Finland
Other neoplasms of lymphoid tissue, Neoplasma benignum sive NUD medullae osseae
+∞
12.6
12
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
12.6
12
*
9940/3-C42.1
ICD-O-3
Hairy cell leukemia, NOS, of bone marrow
+∞
12.6
12
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
12.6
12
*
D47.0
ICD-10 Finland
Histiocytic and mast cell tumours of uncertain and unknown behaviour
+∞
12.6
12
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
12.6
12
*
C91.4
ICD-10 Finland
Hairy-cell leukaemia
+∞
12.6
12
*
XX9CD
NOMESCO Finland
Very extensive complementary CT
+∞
12.6
12
*
116
Kela drug reimbursment
Prostate cancer
+∞
12.6
12
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.5
12.0
61
207
WX302
NOMESCO Finland
Thoracal epidural anesthesy
13.3
11.8
20
16
B01AB05
ATC
enoxaparin; parenteral
2.6
11.6
102
495
PJD45
NOMESCO Finland
Excision of inguinal lymph nodes
+∞
11.5
11
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
11.5
11
*
9732/3-C42.1
ICD-O-3
Plasma cell myeloma of bone marrow
+∞
11.5
11
*
A04AD12
ATC
aprepitant; systemic
+∞
11.5
11
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
+∞
11.5
11
*
H02AB06
ATC
prednisolone; systemic
2.4
11.3
159
984
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
4.3
10.5
39
100
C83.39
ICD-10 Finland
Diffuse non-Hodgkin's large cell lymphoma UNS
+∞
10.5
10
*
2024A
ICD-9 Finland
Other malignant neoplasm of lymphoid and histiocytic tissue, Leukaemic reticuloendotheliosis
+∞
10.5
10
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
+∞
10.5
10
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
5.9
10.5
29
54
JN6AD
NOMESCO Finland
CT of torso and neck
33.9
10.4
13
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
24.4
10.3
14
6
TPH04
NOMESCO Finland
Cathetrisation of vein
2.7
10.3
79
350
WZC30
NOMESCO Finland
Teaching
3.8
9.7
42
124
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
103.3
9.5
10
*
R59.9
ICD-10 Finland
Enlarged lymph nodes, unspecified
22.6
9.4
13
6
HAC20
NOMESCO Finland
Total mastectomy
+∞
9.4
9
*
20228
ICD-8 Finland
Other neoplasms of lymphoid tissue, Other primary malignant neoplasms of lymphoid tissue
+∞
9.4
9
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
9.4
9
*
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
+∞
9.4
9
*
L01CB01
ATC
etoposide; systemic
+∞
9.4
9
*
C81.0
ICD-10 Finland
Nodular lymphocyte predominant Hodgkin lymphoma
+∞
9.4
9
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.6
9.1
31
73
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.7
8.9
64
271
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.3
8.9
103
564
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
9.4
8.7
17
19
HA1AA
NOMESCO Finland
X-ray mammography
8.3
8.5
18
23
9650/3-C77.0
ICD-O-3
Hodgkin lymphoma, NOS, of lymph nodes of head, face and neck
+∞
8.4
8
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
8.4
8
*
9741/3-C42.1
ICD-O-3
Malignant mastocytosis of bone marrow
+∞
8.4
8
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
8.4
8
*
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
+∞
8.4
8
*
ZX112
NOMESCO Finland
Subcutaneous
17.8
8.1
12
7
L02BG04
ATC
letrozole; oral
22.8
8.1
11
5
R4110
NOMESCO Finland
Physiotherapy
2.3
8.0
85
439
WX892
NOMESCO Finland
Monitored bed care
3.6
8.0
36
111
WX408
NOMESCO Finland
General anesthesy, balanced
2.3
7.8
80
406
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
5.4
7.7
22
43
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
25.8
7.6
10
*
B01AB10
ATC
tinzaparin; parenteral
4.5
7.4
25
59
R4190
NOMESCO Finland
Nutritional therapy
7.2
7.4
17
25
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.5
7.3
34
107
C50.99
ICD-10 Finland
Breast, unspecified
+∞
7.3
7
*
C82.01
ICD-10 Finland
Follicular nodular lymphoma, grade I
+∞
7.3
7
*
L01AA02
ATC
chlorambucil; oral
+∞
7.3
7
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
7.3
7
*
C82.2
ICD-10 Finland
Follicular lymphoma grade III, unspecified
+∞
7.3
7
*
9591/3-C77.0
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lymph nodes of head, face and neck
+∞
7.3
7
*
WW300
NOMESCO Finland
Transfer of autologic stem cells
+∞
7.3
7
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
7.3
7
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
7.3
7
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
7.3
7
*
L03AA04
ATC
NA
+∞
7.3
7
*
9680/3-C77.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph node, NOS
+∞
7.3
7
*
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
+∞
7.3
7
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
7.3
7
*
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
3.5
7.3
33
102
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
30.8
7.2
9
*
WX402
NOMESCO Finland
General anaesthesia
2.8
6.9
46
184
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.9
6.8
144
983
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
41.0
6.8
8
*
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
41.0
6.8
8
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.1
6.8
93
537
J05AB01
ATC
aciclovir; systemic
2.4
6.7
63
306
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
4.4
6.7
23
56
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.2
6.6
34
116
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
12.6
6.6
11
9
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
5.6
6.6
18
34
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.3
6.5
66
333
D38.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Mediastinum
71.4
6.5
7
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
7.3
6.3
14
20
2029X
ICD-9 Finland
Other malignant neoplasm of lymphoid and histiocytic tissue, Other and unspecified malignant neoplasms of lymphoid and histiocytic tissue
+∞
6.3
6
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
6.3
6
*
C91.9
ICD-10 Finland
Lymphoid leukaemia, unspecified
+∞
6.3
6
*
C81.2
ICD-10 Finland
Mixed cellularity classical Hodgkin lymphoma
+∞
6.3
6
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
6.3
6
*
2015X
ICD-9 Finland
Hodgkin's disease, Nodular sclerosis[MORBUS HODGKIN, NODULAR SCLEROSIS, NUD]
+∞
6.3
6
*
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
+∞
6.3
6
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
6.3
6
*
9591/3-C77.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lymph node, NOS
+∞
6.3
6
*
2008X
ICD-9 Finland
Lymphosarcoma and reticulosarcoma, Other named variants
+∞
6.3
6
*
9680/3-C77.8
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph nodes of multiple regions
+∞
6.3
6
*
Z85.7
ICD-10 Finland
Personal history of other malignant neoplasms of lymphoid, haematopoietic and related tissues
+∞
6.3
6
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
6.3
6
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
+∞
6.3
6
*
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
+∞
6.3
6
*
C96.1
ICD-10 Finland
Malignant histiocytosis
+∞
6.3
6
*
2000B
ICD-9 Finland
Lymphosarcoma and reticulosarcoma, Reticulosarcoma[LYMPHOMA MALIGNUM DIFFUSUM]
+∞
6.3
6
*
L01AA03
ATC
melphalan; systemic
+∞
6.3
6
*
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
+∞
6.3
6
*
L02BB03
ATC
bicalutamide; oral
+∞
6.3
6
*
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
27.3
6.3
8
*
XF400
NOMESCO Finland
ECG with 12 standard connections
2.3
6.2
62
310
TPX10
NOMESCO Finland
Implantation of vascular injection port
8.9
6.1
12
14
EP1AE
NOMESCO Finland
Neck ultrasound examination
4.8
6.1
19
42
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
182
231
17.36
151.26
8.6
3.0
u/l
284.4
241.0
1.33
175
215
(4035726)
102
64
23.12
125.63
1.8
1.2
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
64
18
44.40
104.53
1.5
1.1
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
106
127
12.09
87.37
1.3
1.4
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
126
221
8.85
75.67
1.4
1.5
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
58
36
19.53
70.21
1.6
2.1
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
123
254
7.32
62.22
1.5
1.4
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
60
6
123.13
57.12
1.4
1.0
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
206
750
6.08
54.74
10.4
5.2
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
129
325
6.04
51.98
1.6
1.8
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
237
1071
5.95
45.96
11.1
5.3
%
2.8
3.0
0.59
229
996
(3022096) Basophils/100 leukocytes in Blood
232
1035
5.75
45.57
11.1
5.4
%
0.7
0.7
0.00
225
960
(3019069) Monocytes/100 leukocytes in Blood
237
1076
5.90
45.55
11.3
5.6
%
9.6
8.7
2.34
230
1005
(3002030) Lymphocytes/100 leukocytes in Blood
238
1101
5.80
44.20
11.1
5.5
%
27.3
27.6
0.09
231
1018
(3005719) IgG [Mass/volume] in Serum or Plasma
81
151
6.88
44.10
4.6
1.8
g/l
9.9
10.9
0.70
76
141
(3018010) Neutrophils/100 leukocytes in Blood
234
1094
5.47
42.12
10.4
5.3
%
55.5
57.4
1.23
226
1019
(3001604) Monocytes [#/volume] in Blood
241
1155
5.67
42.00
10.2
5.1
e9/l
0.6
0.6
0.96
216
990
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
55
71
9.18
41.34
4.6
1.5
mg/l
47.3
29.1
1.07
46
61
(3006315) Basophils [#/volume] in Blood
241
1164
5.60
41.32
10.2
5.1
e9/l
0.0
0.0
0.15
216
1002
(3013115) Eosinophils [#/volume] in Blood
245
1205
5.70
40.89
10.9
5.3
e9/l
0.2
0.2
1.12
225
1056
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
38
29
14.77
40.68
1.5
1.2
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
255
1300
6.12
40.57
22.1
6.1
e9/l
4.1
4.3
0.23
239
1135
(3019198) Lymphocytes [#/volume] in Blood
242
1184
5.55
40.50
10.3
5.2
e9/l
2.0
1.8
0.30
227
1034
(3034860) Kappa light chains.free [Mass/volume] in Serum
54
70
9.11
40.42
4.6
1.5
mg/l
55.0
45.7
0.41
45
60
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
239
1182
5.28
38.76
12.9
3.8
umol/l
10.6
12.2
1.63
234
1109
(3024561) Albumin [Mass/volume] in Serum or Plasma
219
1017
4.81
38.51
9.2
3.8
g/l
33.6
35.7
5.96
213
937
(3004588) Protein electrophoresis panel - Serum or Plasma
78
159
6.20
38.49
3.3
1.4
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
107
294
5.00
37.58
3.5
2.2
%
1.7
1.8
0.54
101
265
(3012095) Magnesium [Moles/volume] in Serum or Plasma
115
336
4.82
37.41
5.9
2.7
mmol/l
0.8
0.8
0.91
109
309
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
36
30
13.42
36.53
1.5
1.2
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
58
93
7.42
36.07
3.7
1.4
g/l
7.5
7.8
0.42
49
69
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
53
77
8.08
35.96
3.7
1.3
g/l
1.1
0.5
0.55
48
66
(3011412) CD3 cells [#/volume] in Blood
27
13
22.63
35.94
2.6
1.3
e9/l
1.4
1.2
—
21
8
(3026493) Urate [Moles/volume] in Serum or Plasma
165
658
4.18
34.91
5.7
2.4
umol/l
335.9
9999.2
3.78
158
567
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
57
93
7.27
34.84
3.7
1.4
g/l
3.9
3.9
0.06
48
66
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
57
93
7.27
34.84
3.7
1.4
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
55
88
7.36
34.20
3.7
1.4
g/l
3.5
3.2
0.97
49
67
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
132
460
4.23
33.51
6.4
2.2
mmol/l
2.5
2.4
6.56
125
388
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
34
30
12.59
33.24
1.5
1.1
—
—
—
0
0
(40758558) Short blood count panel - Blood
141
523
4.08
32.64
18.4
4.4
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
23
10
24.74
31.74
2.0
1.4
%
16.8
8.0
—
10
5
(3018418) pH of Serum or Plasma
165
693
3.91
31.66
8.4
2.9
ph
7.4
7.4
0.31
37
108
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
31
27
12.63
30.49
1.5
1.1
u/ml
237.0
269.6
0.17
20
16
(3023520) Reticulocytes [#/volume] in Blood
82
215
4.81
29.91
4.3
2.3
e9/l
67.8
67.6
0.01
61
168
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
33
34
10.73
29.05
2.1
1.4
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
99
307
4.25
28.98
2.4
2.4
%
21.3
24.1
1.06
90
262
(3048929) Epstein Barr virus Ab [Presence] in Serum
39
51
8.59
28.71
1.6
1.2
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
153
646
3.67
28.44
7.9
4.0
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
102
328
4.12
28.33
2.3
2.3
g/l
2.2
2.3
1.50
96
302
(40760888) Immunoglobulin light chains.free panel - Serum
38
49
8.69
28.28
5.2
1.4
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
58
118
5.80
28.24
2.6
1.5
ug/l
45.7
5.3
0.83
45
92
(3015377) Calcium [Moles/volume] in Serum or Plasma
170
772
3.62
28.12
7.8
2.0
mmol/l
2.4
2.4
0.08
156
631
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
208
1080
3.74
27.74
10.9
5.3
mmol/l
1.2
1.2
0.15
203
963
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
219
1198
3.74
26.42
11.8
5.7
mmol/l
1.2
1.2
0.53
185
1031
(3022948) Iron [Moles/volume] in Serum or Plasma
105
367
3.80
25.59
2.4
2.3
umol/l
11.8
13.7
1.63
100
335
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
36
49
8.17
25.57
2.2
1.9
u/ml
488.5
16.1
1.02
25
37
(3017181) Myelocytes/100 leukocytes in Blood
66
164
4.83
25.46
8.2
4.8
%
1.0
0.7
0.71
41
41
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
35
47
8.26
25.13
2.1
1.3
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
32
42
8.37
23.37
2.0
1.3
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
61
155
4.64
22.77
8.6
4.9
%
0.4
0.1
0.95
37
35
(3002179) Metamyelocytes/100 leukocytes in Blood
60
151
4.68
22.66
8.2
4.9
%
0.7
0.2
1.45
32
30
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
34
50
7.50
22.54
2.1
1.3
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
191
1027
3.19
22.30
17.8
8.0
e9/l
0.0
0.0
0.63
166
818
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
20
14
15.19
22.11
3.1
1.3
u/ml
3304.2
1001.2
1.18
20
14
(40768804) Tissue Pathology biopsy report
152
722
3.14
21.98
2.7
1.6
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
38
65
6.51
21.91
2.2
1.6
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
48
103
5.32
21.85
2.0
1.8
g/l
1.4
1.5
0.25
39
90
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
78
261
3.65
19.80
4.6
2.4
umol/l
8.3
7.1
0.26
72
226
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
23
25
9.85
19.32
1.8
1.4
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
133
636
2.89
18.27
3.7
2.8
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
24
30
8.58
18.14
1.8
1.4
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
52
139
4.29
18.02
1.9
1.5
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
135
659
2.84
17.73
3.9
2.8
e6/l
0.4
0.5
0.30
110
486
(3044640) Blood type and Crossmatch panel - Blood
136
671
2.81
17.45
4.4
2.2
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
98
405
3.06
17.43
2.2
1.7
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
53
149
4.08
17.14
7.8
5.0
%
0.0
0.0
0.01
32
31
(3002582) Erythrocytes [#/volume] in Urine
141
718
2.75
16.89
3.9
2.9
e6/l
45.6
156.5
0.62
117
549
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
16
0
+∞
16.82
5.1
0.0
umol/l
0.3
—
—
16
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
178
1030
2.68
16.35
5.6
3.9
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
260
1834
3.43
16.26
18.7
5.2
u/l
91.6
75.4
4.51
254
1672
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
22
9
26.15
16.24
2.0
1.4
—
—
—
0
0
(3036489) Thrombin time
33
67
5.39
15.85
2.9
2.1
s
21.8
20.7
0.63
33
60
(3001122) Ferritin [Mass/volume] in Serum or Plasma
173
1000
2.63
15.73
3.8
2.7
ug/l
373.8
131.5
2.98
165
919
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
77
293
3.16
15.63
1.8
1.7
—
—
—
0
0
(21494434) Karyotype in Bone marrow
20
24
8.83
15.55
1.3
1.2
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
77
294
3.15
15.53
1.9
1.7
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
21
27
8.26
15.47
1.2
1.2
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
125
625
2.66
15.21
2.1
2.1
mg/l
3.1
3.0
0.06
108
532
(44806118)
18
20
9.49
14.80
1.4
1.3
—
—
—
0
0
(44790047)
18
20
9.49
14.80
1.4
1.3
—
—
—
0
0
(44790048)
18
20
9.49
14.80
1.4
1.3
—
—
—
0
0
(44790049)
18
20
9.49
14.80
1.4
1.3
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
153
857
2.53
14.54
4.2
2.9
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
59
203
3.35
14.05
7.6
6.2
mmol/l
11.6
10.9
0.24
54
192
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
31
68
4.95
13.62
2.0
3.3
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
167
1000
2.43
13.39
12.2
10.4
inr
1.3
1.3
0.08
43
277
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
105
508
2.60
13.38
2.2
1.6
mg/l
3.3
1.1
0.70
85
390
(3018095) Leukocytes [#/volume] in Urine
148
845
2.42
13.14
4.7
3.3
e6/l
431.8
105.9
0.37
118
594
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
16
18
9.31
13.00
2.4
1.2
—
—
—
0
0
(3002256) Pathology report gross observation
53
181
3.32
12.72
1.4
1.1
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
17
7
25.56
12.60
3.2
1.4
e9/l
0.1
0.2
—
17
7
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
14
14
10.42
12.32
2.8
2.3
—
—
—
0
0
(3000991) Gas panel - Venous blood
55
196
3.19
12.30
7.8
7.1
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
79
345
2.72
12.24
1.8
2.0
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
104
521
2.49
12.15
4.4
2.1
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
93
443
2.56
12.08
2.6
1.3
g/l
2.3
2.6
0.46
66
260
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
16
20
8.38
11.99
2.4
1.3
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
17
23
7.76
11.96
1.1
1.1
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
130
724
2.36
11.95
4.3
2.7
u/l
35.5
35.2
0.03
124
685
(3013707) Erythrocyte sedimentation rate by Westergren method
249
1841
2.70
11.85
6.7
4.0
mm/h
18.0
12.1
4.62
239
1669
(3026782) Osmolality of Urine
96
471
2.50
11.66
3.3
2.4
mosm/kgh2o
499.1
560.0
2.34
88
385
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
11
0
+∞
11.53
1.3
0.0
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
211
1459
2.36
11.44
7.4
4.5
mmol/l
6.6
6.8
0.56
202
1355
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
13
13
10.39
11.41
1.5
1.2
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
23
46
5.32
11.18
1.5
1.3
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
18
29
6.52
10.85
1.6
1.4
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
20
36
5.87
10.84
1.5
1.4
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
100
517
2.37
10.70
3.1
2.2
e6/l
5.3
4.9
0.07
92
447
(3002032) Base excess in Venous blood by calculation
60
244
2.80
10.55
4.4
3.2
mmol/l
2.0
2.1
0.08
46
197
(40760892) CBC W Ordered Manual Differential panel - Blood
95
485
2.37
10.43
9.5
4.6
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
25
60
4.44
9.83
1.3
1.2
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
77
368
2.45
9.72
3.5
2.8
e6/l
1.8
2.2
0.17
43
191
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
27
70
4.13
9.62
2.9
2.5
u/ml
0.2
0.3
1.27
18
35
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
23
53
4.60
9.50
1.4
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
23
53
4.60
9.50
1.4
1.4
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
19
37
5.40
9.48
4.3
3.2
%
52.4
58.1
0.67
19
37
(40765096) Chromosome analysis panel by Banding
13
6
22.51
9.42
1.2
1.0
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
97
519
2.26
9.42
4.5
3.7
ng/l
280.5
297.7
0.03
79
431
(3014576) Chloride [Moles/volume] in Serum or Plasma
66
298
2.54
9.38
8.0
5.8
mmol/l
104.3
104.6
0.22
66
293
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
81
402
2.37
9.37
3.6
2.6
e6/l
0.8
1.1
0.42
48
225
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
14
9
16.20
9.12
1.6
1.2
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
17
31
5.74
9.07
1.1
1.0
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
52
213
2.73
8.96
2.8
2.0
u/l
30.4
31.2
0.06
44
173
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
11
13
8.73
8.51
1.1
1.2
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
12
17
7.30
8.05
2.7
1.6
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
12
17
7.30
8.05
2.7
1.6
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
123
767
1.99
7.74
2.7
2.3
u/l
49.9
57.0
1.67
108
705
(3030905) Polymorphonuclear cells [#/volume] in Blood
17
36
4.94
7.73
4.2
2.7
e9/l
3.3
4.5
1.53
17
36
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
23
63
3.86
7.61
2.0
1.2
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
13
22
6.12
7.44
3.1
1.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
99
583
2.02
7.24
1.5
1.4
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
157
1088
1.89
7.03
2.1
2.0
pmol/l
87.9
94.0
0.89
94
564
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
22
62
3.74
7.00
1.6
1.5
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
145
985
1.88
6.86
2.9
2.3
nmol/l
79.6
77.6
0.36
135
854
(3021960) Folate [Moles/volume] in Serum or Plasma
104
642
1.93
6.54
1.4
1.5
nmol/l
18.7
20.4
0.65
91
545
(3016650) Hepatitis A virus Ab [Presence] in Serum
16
38
4.38
6.36
1.1
1.1
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
13
26
5.17
6.28
4.6
3.0
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
58
294
2.19
6.22
1.6
1.3
titre
1260.0
506.1
0.75
12
75
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
11
19
5.96
6.15
2.7
1.2
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
11
19
5.96
6.15
2.7
1.2
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
11
19
5.96
6.15
2.7
1.2
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
50
240
2.29
6.10
5.6
3.0
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
14
31
4.68
6.04
1.6
1.5
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
43
195
2.40
5.96
4.0
3.7
ng/l
76.5
84.7
0.32
38
171
(3005322) IgE [Units/volume] in Serum or Plasma
33
132
2.68
5.92
1.3
1.2
u/ml
451.1
216.3
0.59
27
119
(40768806) Pleura Pathology biopsy report
11
20
5.66
5.85
1.4
1.2
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
122
817
1.81
5.82
4.2
3.0
ng/l
1852.5
1580.8
0.34
112
684
(3007853) Bacteria identified in Skin by Aerobe culture
55
282
2.15
5.71
1.7
1.7
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
87
532
1.88
5.51
1.8
1.7
nmol/l
995.9
1177.6
1.41
70
392
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
10
18
5.71
5.35
3.9
1.9
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
20
64
3.27
5.29
3.3
3.9
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
5
0
+∞
5.22
2.2
0.0
—
—
—
0
0
(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum
5
0
+∞
5.22
1.0
0.0
u/ml
0.0
—
—
5
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
13
31
4.33
5.14
1.3
1.3
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
12
27
4.58
5.08
1.8
1.5
—
—
—
0
0
(4062490)
11
23
4.92
5.05
1.2
1.3
—
—
—
0
0
(3044889) 12 lead EKG panel
217
1762
1.75
4.92
5.1
4.0
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
10
20
5.13
4.81
2.2
1.5
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
10
20
5.13
4.81
8.7
4.6
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
15
43
3.61
4.67
1.1
1.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
16
48
3.46
4.67
1.1
1.1
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
13
35
3.83
4.41
1.1
1.2
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
18
63
2.97
4.13
1.2
1.3
e6/l
8.8
427.9
0.82
13
54
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
18
63
2.97
4.13
1.2
1.1
e6/l
12.9
51.0
0.37
12
52
(3024891) Influenza virus A+B Ag [Presence] in Specimen
18
63
2.97
4.13
1.4
1.2
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
10
23
4.46
4.12
1.0
1.0
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
8
10
8.17
4.08
1.4
1.8
nmol/l
3.8
3.8
—
8
10
(3026008) Bacteria identified in Urine by Culture
107
749
1.65
4.07
3.6
3.1
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
7
7
10.19
4.03
2.7
1.6
ug/l
39.0
77.4
—
7
7
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
11
28
4.03
4.01
1.1
1.1
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
55
321
1.86
3.95
1.5
1.2
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
10
24
4.27
3.91
1.4
1.2
—
—
—
0
0
(40768793) Breast Pathology biopsy report
10
24
4.27
3.91
1.5
1.1
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
8
11
7.43
3.88
2.1
1.8
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
8
11
7.43
3.88
2.1
1.8
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
37
190
2.07
3.82
4.7
3.1
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
7
8
8.91
3.79
5.0
2.0
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
6
5
12.19
3.78
2.8
1.0
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
6
5
12.19
3.78
1.2
1.0
—
—
—
0
0
(3024471) HLA-A [Type]
6
5
12.19
3.78
1.0
1.0
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
59
357
1.80
3.77
35.3
26.5
inr
1.1
1.3
—
5
49
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
9
16
5.76
3.68
1.7
1.3
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
21
86
2.55
3.63
1.8
1.5
—
—
—
0
0
(40768443) Skin Pathology biopsy report
23
99
2.43
3.60
1.2
1.2
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
10
26
3.94
3.55
1.0
1.1
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
9
17
5.42
3.53
1.1
1.2
u/l
388.3
233.4
—
9
17
(3014148) Varicella zoster virus Ab [Titer] in Serum
9
17
5.42
3.53
1.0
1.1
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
6
6
10.16
3.51
6.2
7.3
—
—
—
0
0
(3010421) pH of Blood
16
58
2.85
3.47
4.5
4.0
ph
7.4
7.4
0.54
16
48
(3014765) Yersinia sp identified in Stool by Organism specific culture
19
76
2.60
3.45
1.2
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
19
76
2.60
3.45
1.2
1.1
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
10
27
3.79
3.38
1.9
1.4
%
89.1
89.8
—
10
27
(42529406) Shigella sp [Presence] in Stool by Culture
19
77
2.56
3.36
1.2
1.2
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
14
5.83
3.36
2.0
1.6
—
—
—
0
0
(3000012) Reticulocyte production index
8
14
5.83
3.36
2.0
1.7
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
202
1690
1.55
3.35
5.3
4.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
25
116
2.26
3.32
1.4
1.3
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
24
110
2.28
3.28
1.3
1.3
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
6
7
8.71
3.27
3.7
1.3
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
18
74
2.52
3.11
1.7
1.7
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
10
29
3.53
3.07
4.5
1.4
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
13
45
2.97
3.06
1.2
2.3
—
—
—
0
0
(3024932) HLA-DR beta [Type]
5
5
10.13
2.99
1.2
1.4
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
5
5
10.13
2.99
1.4
1.0
nmol/l
107.0
66.6
—
5
5
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
21
95
2.30
2.97
2.7
1.6
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
6
9
6.77
2.88
1.0
1.0
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
28
145
2.02
2.85
1.6
1.4
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
13
47
2.84
2.85
1.2
1.6
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
14
53
2.72
2.83
9.6
2.2
mg/l
2.1
1.6
0.51
14
47
(3029937) Albumin [Presence] in Urine by Test strip
89
644
1.53
2.81
5.5
4.0
estimate
0.0
0.0
0.00
38
190
(1761868) Lipid panel - Serum or Plasma
56
821
0.61
2.80
3.2
3.1
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
6
10
6.09
2.71
3.8
1.2
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
6
10
6.09
2.71
3.8
1.2
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
6
10
6.09
2.71
1.3
1.1
u/l
11.8
17.2
—
6
10
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
6
10
6.09
2.71
3.8
1.2
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
6
10
6.09
2.71
3.8
1.2
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
271
2472
1.70
2.70
36.1
12.9
mg/l
27.4
23.6
1.28
250
1917
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
9
24
3.83
2.69
1.2
1.0
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
5
7
7.24
2.56
4.2
1.1
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
5
7
7.24
2.56
1.2
1.0
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
5
7
7.24
2.56
4.2
1.1
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
46
290
1.69
2.55
8.2
7.9
mmol/l
0.9
1.6
0.66
39
226
(3016018) Differential panel - Cerebral spinal fluid
9
26
3.53
2.50
1.0
1.1
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
9
26
3.53
2.50
3.3
1.5
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
7
16
4.45
2.49
3.6
1.5
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
7
16
4.45
2.49
1.1
1.4
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
42
262
1.70
2.42
8.7
8.1
%
95.6
94.8
0.28
42
253
(40768441) Liver Pathology biopsy report
6
12
5.07
2.41
1.0
1.0
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
38
233
1.72
2.33
9.5
8.9
g/l
118.0
122.6
0.71
38
227
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
128
1027
1.42
2.32
4.6
3.8
ng/l
28.2
43.0
1.61
96
747
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
23
121
1.97
2.27
12.0
12.1
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
7
18
3.95
2.26
1.0
1.0
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
7
18
3.95
2.26
1.4
1.6
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
255
2325
1.52
2.18
32.4
11.8
ml/min/173m2
78.7
78.0
0.16
232
1856
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
50
336
1.58
2.17
1.4
1.5
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
7
19
3.74
2.16
1.6
1.3
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
224
2454
0.70
2.14
4.3
4.7
mmol/l
1.3
1.5
4.79
201
2239
(3019832) Treponema pallidum Ab [Presence] in Serum
26
146
1.85
2.14
1.3
1.8
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
244
2209
1.47
2.13
34.1
14.1
%
37.2
39.9
5.33
179
1497
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
227
2476
0.70
2.05
4.4
4.7
mmol/l
4.3
4.6
2.83
207
2269
(3020891) Body temperature
19
97
2.02
2.05
4.2
5.1
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
233
2529
0.69
2.03
4.9
5.3
mmol/l
2.5
2.7
1.79
206
2311
(3023419) Bacteria identified in Sputum by Culture
9
33
2.78
1.94
3.0
3.2
—
—
—
0
0
(4281824)
6
16
3.80
1.94
1.3
1.0
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
8
28
2.90
1.87
1.5
1.6
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
141
1182
1.35
1.86
5.0
3.7
estimate
0.0
0.0
0.00
40
196
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
42
282
1.56
1.84
1.5
1.4
—
—
—
0
0
(4268621)
7
23
3.09
1.81
2.4
2.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
11
47
2.39
1.79
1.1
1.4
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
15
74
2.08
1.78
1.4
1.7
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
180
1574
1.34
1.75
3.6
2.9
u/l
68.6
44.8
1.66
164
1460
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
216
2357
0.73
1.74
5.9
6.2
mmol/mol
40.4
40.4
0.01
190
2167
(3019897) Erythrocyte distribution width [Ratio] by Automated count
5
13
3.89
1.72
4.2
2.7
%
13.4
13.9
—
5
13
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
0
47
0.00
1.72
0.0
1.4
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
142
1205
1.33
1.68
5.0
3.7
estimate
0.0
0.0
0.00
40
193
(3022145) Colonoscopy Study observation
36
239
1.57
1.66
1.4
1.3
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
140
1188
1.32
1.65
6.5
4.9
estimate
0.0
0.0
0.00
41
192
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
67
507
1.41
1.64
1.2
1.3
u/ml
0.5
1.9
2.16
14
140
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
8
171
0.45
1.64
2.9
1.9
—
—
—
0
0
(3019060) Gas panel - Arterial blood
27
170
1.64
1.55
6.3
7.3
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
8
33
2.46
1.55
2.4
2.4
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
24
148
1.67
1.49
1.7
1.6
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
41
292
1.46
1.39
1.9
1.5
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
6
23
2.64
1.37
1.0
1.5
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
206
1871
1.29
1.36
4.3
3.7
pmol/l
15.0
14.9
0.10
187
1673
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
220
2367
0.76
1.35
4.2
4.2
mmol/l
1.3
1.3
0.85
195
2141
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
9
42
2.18
1.35
1.4
1.3
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
9
43
2.12
1.31
2.4
1.2
—
—
—
0
0
(1616796) Gas panel - Central venous blood
10
48
2.12
1.29
6.8
3.4
—
—
—
0
0
(3017704) Immunofixation for Urine
5
18
2.81
1.29
1.8
1.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
8
36
2.25
1.25
1.5
1.5
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
96
801
1.29
1.22
2.1
2.1
u/l
154.9
329.4
0.90
91
749
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
5
19
2.66
1.22
1.0
1.3
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
18
109
1.69
1.21
7.7
8.1
%
1.5
1.7
0.53
18
104
(3007930) Methemoglobin/Hemoglobin.total in Blood
18
109
1.69
1.21
7.7
8.1
%
0.8
0.9
1.07
18
104
(3041096) Erythrocytes [Presence] in Urine by Automated
79
645
1.30
1.19
4.0
3.3
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
10
184
0.53
1.18
1.5
1.4
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
274
2611
1.39
1.14
35.6
15.7
mmol/l
139.3
139.8
3.14
268
2530
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
7
31
2.29
1.11
1.0
1.0
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
274
2615
1.38
1.09
36.8
15.8
mmol/l
4.0
4.0
0.58
268
2532
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
277
2649
1.39
1.07
22.0
8.7
u/l
25.9
25.4
0.22
271
2530
(3017732) Neutrophils [#/volume] in Blood
25
171
1.50
1.06
3.0
2.5
e9/l
3.7
3.6
0.08
20
129
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
109
939
1.25
1.05
5.3
3.8
—
—
—
0
0
(3000492) Spirometry study
30
214
1.44
1.04
1.8
1.4
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
11
60
1.86
1.04
3.5
3.0
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
5
22
2.29
1.04
2.4
2.9
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
24
341
0.68
1.02
4.5
4.8
%
29.2
32.2
0.74
15
219
(4094501)
12
68
1.80
1.02
1.2
1.1
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
24
165
1.49
1.00
9.4
9.3
mmol/l
25.2
24.4
0.54
24
156
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
10
54
1.88
0.97
1.2
1.1
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
7
36
1.97
0.97
1.0
1.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
6
27
2.25
0.94
1.5
1.1
—
—
—
0
0
(4306422)
6
28
2.16
0.92
1.2
1.3
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
6
29
2.09
0.90
1.2
1.2
—
—
—
0
0
(4010399)
24
170
1.45
0.88
1.3
1.5
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
30
2.02
0.87
1.0
1.1
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
34
258
1.36
0.86
2.0
2.6
ug/l
2.8
7.1
3.15
29
220
(3022621) pH of Urine by Test strip
10
165
0.59
0.84
2.8
2.8
—
—
—
0
0
(3015736) pH of Urine
107
941
1.21
0.83
5.0
3.5
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
48
386
1.29
0.82
1.2
1.3
u/ml
3.7
12.0
1.44
14
142
(3019230) Fractional oxyhemoglobin in Venous blood
8
47
1.72
0.81
1.5
1.8
%
55.8
64.1
—
8
47
(3037121) Protein [Mass/volume] in Urine
13
82
1.61
0.79
2.9
2.2
g/l
0.1
0.3
—
8
24
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
0
26
0.00
0.79
0.0
1.2
—
81.8
—
0
6
(3038177) Helicobacter pylori Ab [Presence] in Serum
6
34
1.78
0.76
1.3
1.3
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
5
24
2.10
0.75
3.4
1.1
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
5
24
2.10
0.75
3.4
1.1
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
5
24
2.10
0.75
3.4
1.1
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
5
24
2.10
0.75
3.4
1.1
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
5
24
2.10
0.75
3.4
1.1
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
5
24
2.10
0.75
3.4
1.1
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
13
84
1.57
0.73
2.8
2.3
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
152
1393
1.18
0.72
2.9
2.7
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
11
68
1.64
0.72
1.5
1.3
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
5
27
1.87
0.68
1.2
1.2
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
5
28
1.80
0.66
7.0
3.6
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
5
29
1.74
0.64
1.2
1.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
20
266
0.74
0.62
1.8
1.6
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
20
0.00
0.60
0.0
1.6
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
23
175
1.34
0.60
2.0
2.4
—
22.9
—
0
5
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
6
37
1.63
0.56
1.3
1.3
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
23
180
1.30
0.51
1.2
1.2
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
64
565
1.17
0.48
5.8
3.7
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
8
121
0.65
0.46
2.1
1.5
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
16
208
0.76
0.45
1.2
2.1
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
237
2289
1.14
0.44
5.3
4.5
mu/l
2.0
2.0
0.27
219
2062
(3012516) Albumin [Mass/volume] in Urine
75
829
0.87
0.43
3.4
3.2
mg/l
36.0
270.8
1.16
49
542
(3020874) Milk IgE Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.2
—
4.7
—
0
7
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.6
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
0
15
0.00
0.41
0.0
2.6
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
62
554
1.15
0.40
1.7
1.7
pmol/l
469.5
430.9
0.52
50
450
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
3.5
—
32.0
—
0
11
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
48
422
1.16
0.39
1.2
1.3
iu/ml
39.2
32.5
0.10
13
124
(3020682) Albumin/Creatinine [Ratio] in Urine
80
873
0.89
0.38
3.8
4.0
mg/mmol
5.5
7.3
0.58
53
559
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
18
222
0.80
0.36
1.4
2.3
—
—
—
0
0
(3019225) pH of Specimen
28
237
1.20
0.35
5.6
3.8
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
6
46
1.31
0.33
6.0
2.8
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
6
46
1.31
0.33
1.5
1.5
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
20
166
1.22
0.30
15.2
3.9
kpa
5.0
5.1
0.15
20
153
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
13
102
1.29
0.30
20.5
4.6
mmol/l
24.5
24.9
0.23
13
97
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
11
84
1.32
0.30
1.9
1.7
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
7
57
1.23
0.29
1.1
1.5
mu/l
253.6
247.4
—
7
50
(3045414) Leukocytes [Presence] in Urine
11
85
1.30
0.28
1.5
2.0
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
8
64
1.26
0.27
30.1
3.0
kpa
7.8
8.1
—
8
58
(3000475) Leukocytes [#/volume] in Synovial fluid
8
66
1.22
0.27
2.1
1.6
e6/l
2754.9
16047.1
—
8
47
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
36
325
1.12
0.22
9.5
7.3
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
16
135
1.20
0.22
2.6
2.5
—
—
—
0
0
(1002224) Polysomnography panel
12
98
1.23
0.21
1.0
1.1
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
18.0
—
1349.2
—
0
11
(3029075) Extractable nuclear Ab panel - Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.2
—
25.4
—
0
5
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
9.2
—
0.7
—
0
10
(3045683) HLA typing for celiac disease panel - Blood or Tissue
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
11
132
0.83
0.18
4.8
3.5
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
13
153
0.84
0.18
1.5
1.2
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
71
673
1.07
0.17
1.5
1.7
mmol/l
1.4
1.3
0.15
60
551
(3048689) Calprotectin [Mass/mass] in Stool
29
264
1.11
0.16
2.8
2.3
ug/g
156.8
120.8
0.14
23
201
(1761482) Bacteria [#/volume] in Urine by Culture
6
76
0.79
0.16
6.0
4.1
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
100
966
1.05
0.13
4.7
3.9
ug/l
4.1
2.0
0.57
93
862
(3007461) Platelets [#/volume] in Blood
278
2759
1.07
0.10
47.0
18.7
e9/l
234.9
244.1
1.03
268
2675
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
5
45
1.11
0.10
1.2
1.4
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
278
2760
1.06
0.09
47.0
18.8
e12/l
4.2
4.5
16.63
267
2665
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
5
62
0.80
0.08
1.6
1.9
pmol/l
183.8
226.3
—
5
56
(3010813) Leukocytes [#/volume] in Blood
278
2762
1.06
0.08
47.1
18.8
e9/l
7.8
6.7
1.19
266
2669
(3013512) EKG study
79
769
1.04
0.07
5.2
3.9
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
7
80
0.87
0.07
1.6
1.7
—
—
—
0
0
(40761535) Cells panel - Urine sediment
24
226
1.07
0.07
5.6
3.0
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
58
562
1.04
0.07
5.4
4.1
kg/l
1.0
1.0
—
5
92
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
20
187
1.07
0.06
1.8
2.0
ml/min/173m2
67.1
63.9
—
9
75
(3022313) Gas panel - Capillary blood
13
120
1.09
0.05
19.7
4.0
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
18
171
1.06
0.03
1.4
1.5
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
55
539
1.02
0.03
3.1
2.6
ug/l
0.6
0.8
1.59
42
360
(40761511) CBC panel - Blood by Automated count
261
2601
1.02
0.02
24.2
12.2
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
246
2469
0.98
0.02
4.7
4.7
mmol/l
6.0
6.0
0.07
224
2226
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
26
254
1.03
0.00
1.3
1.8
%
1.8
1.5
0.56
19
216
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
10
98
1.02
0.00
1.1
2.1
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
86
861
1.00
0.00
3.1
3.1
mmol/l
7.1
7.7
0.60
66
716
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
11
113
0.97
0.00
1.3
1.0
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
78
777
1.01
0.00
4.2
3.7
%
23.4
24.5
0.22
38
364
(4198724)
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
5
49
1.02
0.00
1.0
1.2
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
0
8
0.00
0.00
0.0
1.1
—
0.6
—
0
8
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
6
0.00
0.00
0.0
2.7
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
6
0.00
0.00
0.0
2.7
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
7
0.00
0.00
0.0
4.7
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
8
79
1.01
0.00
1.1
2.1
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3008898) HLA-B27 [Presence]
8
86
0.93
0.00
1.3
1.1
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
9.2
—
0
8
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
2.9
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: CD2_PRIMARY_LYMPHOID_HEMATOPOIETIC_NAS_EXALLC – Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue
GWS hits: 1
This endpoint is excluded (different definition than used in FinnGen).